ProfileGDS5678 / 1421105_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 12% 13% 13% 14% 11% 12% 13% 13% 13% 19% 13% 14% 13% 13% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3324912
GSM967853U87-EV human glioblastoma xenograft - Control 22.3274513
GSM967854U87-EV human glioblastoma xenograft - Control 32.3315613
GSM967855U87-EV human glioblastoma xenograft - Control 42.3024614
GSM967856U87-EV human glioblastoma xenograft - Control 52.2381911
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3539612
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3595313
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3063113
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3106613
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4452219
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3115713
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3136714
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3135213
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3117813